Your browser doesn't support javascript.
loading
Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment.
Ercolano, Giuseppe; De Cicco, Paola; Rubino, Valentina; Terrazzano, Giuseppe; Ruggiero, Giuseppina; Carriero, Roberta; Kunderfranco, Paolo; Ianaro, Angela.
Affiliation
  • Ercolano G; Department of Oncology UNIL CHUV and Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Lausanne, Switzerland.
  • De Cicco P; Department of Pharmacy, University of Naples Federico II, Naples, Italy.
  • Rubino V; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
  • Terrazzano G; Department of Science, University of Basilicata, Potenza, Italy.
  • Ruggiero G; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
  • Carriero R; Department of Science, University of Basilicata, Potenza, Italy.
  • Kunderfranco P; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
  • Ianaro A; Bioinformatic Unit, Humanitas Clinical and Research Center, Rozzano, Italy.
Front Pharmacol ; 10: 1456, 2019.
Article in En | MEDLINE | ID: mdl-31920649
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Pharmacol Year: 2019 Type: Article Affiliation country: Switzerland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Pharmacol Year: 2019 Type: Article Affiliation country: Switzerland